股息配發率   玩股撇步(動畫小學堂)

  • 現金殖利率: 0.44%、總殖利率: 0.44%、5年平均現金配發率: 80.28%
  • 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
  • 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY現金股利 YoY股票股利 YoY現金配發率 YoY股票配發率 YoY全部配發率 YoY
2025 (5)0.5735.710.8014.290.000140.35-15.790.000140.35-15.79
2024 (4)0.42-47.50.700.00.000166.6790.480.000166.6790.48
2023 (3)0.80-80.250.70-76.670.00087.5018.120.00087.5018.12
每股盈餘-近8季
EPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY
26Q1 (8)1.80190.322900.00.24380.0700.01.80215.792900.0
25Q4 (7)0.6251.221450.00.0525.0155.560.571240.035.71
25Q3 (6)0.41178.854000.00.04-76.47-42.86-0.0589.13-113.16
25Q2 (5)-0.52-966.67-336.360.17525.0325.0-0.46-866.67-221.05
25Q1 (4)0.0650.00.0-0.0455.560.00.06-85.710.0
24Q4 (3)0.04300.00.0-0.09-228.570.00.4210.530.0
24Q3 (2)0.01-95.450.00.0775.00.00.380.00.0
24Q2 (1)0.220.00.00.040.00.00.380.00.0
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比自結稅前EPS自結稅前累計EPS備註(年增率變動50%需說明原因)
2026/6271.35-5.8831.781522.4315.97836.47N/A-
2026/5288.314.1531.351251.0913.03836.8N/A-
2026/4276.811.8919.43962.788.5734.05N/A-
2026/3271.6746.418.05685.964.64685.960.82-
2026/2185.56-18.87-15.96414.29-2.6635.270.88-
2026/1228.733.511.8228.7311.8661.010.85-
2025/12220.984.57-5.662599.030.11644.580.8-
2025/11211.31-0.46-3.82378.050.68645.320.8-
2025/10212.29-4.24-6.712166.741.14642.540.8-
2025/9221.726.323.461954.452.08641.770.79-
2025/8208.53-1.41-7.171732.741.9625.960.81-
2025/7211.532.73-6.111524.23.28636.920.8-
2025/6205.9-6.19-5.61312.684.98657.160.75-
2025/5219.49-5.29-3.361106.787.22681.390.73-
2025/4231.770.715.92887.2810.2682.70.73-
2025/3230.134.226.9655.5211.8655.520.77-
2025/2220.817.9232.12425.3914.64659.710.77-
2025/1204.58-12.690.32204.580.32658.560.77-
2024/12234.326.6715.232596.15-0.05681.560.76-
2024/11219.65-3.484.922361.83-1.35661.520.78-
2024/10227.586.24.762142.18-1.95666.510.78-
2024/9214.28-4.61-3.221914.6-2.69664.230.81-
2024/8224.64-0.29-4.791700.31-2.62668.080.8-
2024/7225.313.294.721475.67-2.29670.570.8-
2024/6218.13-3.9610.211250.36-3.45664.060.76-
2024/5227.143.810.531032.24-5.92661.190.76-
2024/4218.81.642.45805.1-7.59601.170.84-
2024/3215.2628.8-8.94586.3-10.86586.3N/A-
2024/2167.11-18.05-23.49371.04-11.93572.71N/A-
2024/1203.931.120.5203.930.5614.95N/A-
2023/12201.67-3.67-15.752595.88-26.91628.24N/A-
2023/11209.35-3.62-16.932394.21-27.72647.99N/A-
2023/10217.22-1.89-18.422184.86-28.6674.59N/A-
2023/9221.41-6.16-18.321967.63-29.57672.51N/A-
2023/8235.969.67-14.221746.22-30.78649.0N/A-
2023/7215.158.71-23.081510.27-32.81638.98N/A-
2023/6197.9-12.4-38.441295.12-34.19637.38N/A-
2023/5225.935.79-31.291097.22-33.36675.89N/A-
2023/4213.55-9.67-28.09871.29-33.88668.39N/A-
2023/3236.418.23-36.1657.74-35.57657.74N/A-
2023/2218.437.65-26.75421.33-35.26660.71N/A-
2023/1202.9-15.24-42.46202.9-42.46694.32N/A-
2022/12239.39-5.01-30.73551.83-13.72757.71N/A-
2022/11252.04-5.35-30.083312.45-12.16789.42N/A-
2022/10266.28-1.77-28.93060.41-10.27812.46N/A-
2022/9271.1-1.44-24.082794.13-7.97825.88N/A-
2022/8275.08-1.65-26.492523.03-5.82876.3N/A-
2022/7279.71-13.0-23.982247.95-2.47930.06N/A-
2022/6321.52-2.22-7.071968.241.61947.32N/A-
2022/5328.8310.72-4.641646.723.5995.83N/A-
2022/4296.97-19.74-14.911317.895.75965.23N/A-
2022/3370.0224.077.651020.9213.81020.92N/A-
2022/2298.23-15.4314.74650.917.62996.29N/A-
2022/1352.672.120.17352.6720.171058.53N/A-
2021/12345.39-4.1821.94116.6650.591080.39N/A全球疫情控制、景氣回溫等有利因素,本公司全年營收較去年大幅增加。
2021/11360.47-3.7537.03771.2653.911092.1N/A今年疫情趨緩,全球消費動能回溫,本公司營收較去年同期大幅增加。
2021/10374.534.8751.393410.855.941105.85N/A去年肺炎疫情影響全球經濟活動;今年景氣大幅增溫,本公司營收較去年大幅增加。
2021/9357.1-4.5749.863036.2756.531099.28N/A今年全球疫情逐漸得到控制,各國逐步施打疫苗,使民生需求強力反彈,各行業景氣顯著回溫,帶動本公司各項產品營收大幅增加。
2021/8374.221.768.492679.1757.460.0N/A去年全球經濟活動正開始緩步復甦,而今年本公司處於營運高峰,相較之下,營收大幅增加。
2021/7367.966.3569.152304.9555.80.0N/A今年本公司處於營運高峰,而去年同期部分國家開始有條件解封,全球景氣剛開始由谷底爬升,因此兩相比較之下,營收大幅增加。

股利相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。